|
West Nile Virus (WNV) has spread rapidly across the United
States and Canada since its arrival in North America in 1999.
It
infects over 150 species of birds as well as mammals including
squirrels, dogs, wolves, horses and mountain goats.
Different types of mosquitoes are responsible for risk of
disease in humans. One type feeds on birds and transmits the
virus to other birds, which creates a large reservoir of WNV
infection that starts to build in early spring. Another type
of mosquito feeds on both birds and humans and can transmit
the virus to humans.
While mosquitoes represent the most common route for transmission
of the disease to humans, WNV can also be spread through blood
or organ donation, pregnancy, lactation, needle-stick injury
and exposure to infected laboratory specimens.
Symptoms of WNV range from fever accompanied by malaise,
headache, myalgia, rash, lymphadenopathy, eye pain, anorexia
and vomiting lasting for three to six days, to severe meningo-encephalitis.
Severe muscle weakness and flaccid paralysis have also been
experienced.
A large part of preventing the transmission of WNV relies
on the elimination of mosquito breeding sites and the use
of personal protection.
Public education can promote personal protection, but further
control measures, including the use of larvicides and adulticides,
have also been used to reduce mosquito populations.
Larvicides are used in the spring and early summer to reduce
the number of emerging mosquitoes. They are often in granular,
pellet or teabag formulations and are placed in catch basins
and standing water sites that are close enough to human populations
to pose a risk.
Adulticides are used to kill adult mosquitoes and are applied
from equipment mounted on aircraft or trucks. They are used
as a final measure when other methods to reduce mosquito populations
have failed.
Canadian
Medical Journal May 27, 2003;168 (11)
|